Piper Jaffray downgrades ZymoGenetics, Inc. (Nasdaq: ZGEN) from Buy to Neutral. Price target lowered from $14 to $4.

This article: 142 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE